Massachusetts Financial Services CO Abbott Laboratories Transaction History

Massachusetts Financial Services CO

$299 Billion
Q4 2024

A detailed history of Massachusetts Financial Services CO transactions in Abbott Laboratories stock. As of the latest transaction made, Massachusetts Financial Services CO holds 12,811,351 shares of ABT stock, worth $1.73 Billion. This represents 0.48% of its overall portfolio holdings.

Number of Shares

12,811,351

Previous 13,319,347 3.81%

Holding current value

$1.73 Billion

Previous $1.52 Billion 4.57%

% of portfolio

0.48%

Previous 0.47%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $56.9 Million - $60.6 Million	-507,996 Reduced 3.81%	12,811,351 $1.45 Billion
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $271 Million - $320 Million	2,711,586 Added 25.56%	13,319,347 $1.52 Billion
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $22.2 Million - $24.7 Million	-220,068 Reduced 2.03%	10,607,761 $1.1 Billion
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $134 Million - $148 Million	-1,225,199 Reduced 10.17%	10,827,829 $1.23 Billion
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $139 Million - $170 Million	-1,543,960 Reduced 11.36%	12,053,028 $1.33 Billion
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $435 Million - $522 Million	-4,551,738 Reduced 25.08%	13,596,988 $1.32 Billion
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $303 Million - $337 Million	-3,002,767 Reduced 14.2%	18,148,726 $1.98 Billion
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $356 Million - $419 Million	-3,676,831 Reduced 14.81%	21,151,493 $2.14 Billion
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $28.2 Million - $33.1 Million	296,516 Added 1.21%	24,828,324 $2.73 Billion
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $89.4 Million - $103 Million	-923,795 Reduced 3.63%	24,531,808 $2.37 Billion
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $43.3 Million - $52.4 Million	-424,495 Reduced 1.64%	25,455,603 $2.77 Billion
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $93.3 Million - $114 Million	-818,021 Reduced 3.06%	25,880,098 $3.06 Billion
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $9.58 Million - $11.7 Million	82,926 Added 0.31%	26,698,119 $3.76 Billion
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $8.95 Million - $9.9 Million	-76,714 Reduced 0.29%	26,615,193 $3.14 Billion
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.99 Million - $2.35 Million	18,836 Added 0.07%	26,691,907 $3.09 Billion
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $46.1 Million - $54.3 Million	-423,537 Reduced 1.56%	26,673,071 $3.2 Billion
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $144 Million - $157 Million	1,374,952 Added 5.35%	27,096,608 $2.97 Billion
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $111 Million - $135 Million	1,216,669 Added 4.96%	25,721,656 $2.8 Billion
Q2 2020 Nov 20, 2020	BUY	$76.57 - $98.0 $3.76 Million - $4.81 Million	49,132 Added 0.2%	24,504,987 $2.24 Billion
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $228 Million - $291 Million	-2,974,056 Reduced 10.84%	24,455,855 $2.24 Billion
Q1 2020 Nov 20, 2020	BUY	$62.82 - $91.86 $3.54 Million - $5.18 Million	56,411 Added 0.21%	27,429,911 $2.16 Billion
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $230 Million - $337 Million	-3,666,922 Reduced 11.81%	27,373,500 $2.16 Billion
Q4 2019 Nov 25, 2020	BUY	$78.51 - $87.4 $4.76 Million - $5.3 Million	60,618 Added 0.2%	31,040,422 $2.7 Billion
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $76.3 Million - $84.9 Million	-971,647 Reduced 3.04%	30,979,804 $2.69 Billion
Q3 2019 Nov 20, 2020	BUY	$81.84 - $88.74 $5.11 Million - $5.55 Million	62,487 Added 0.2%	31,951,451 $2.67 Billion
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $23.4 Million - $25.4 Million	-285,849 Reduced 0.89%	31,888,964 $2.67 Billion
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $42.4 Million - $49.4 Million	-581,500 Reduced 1.78%	32,174,813 $2.71 Billion
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $58.5 Million - $70.8 Million	-884,148 Reduced 2.63%	32,756,313 $2.62 Billion
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $325 Million - $368 Million	-4,956,088 Reduced 12.84%	33,640,461 $2.43 Billion
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $33 Million - $39.8 Million	-541,950 Reduced 1.38%	38,596,549 $2.83 Billion
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $38.9 Million - $42.9 Million	-674,986 Reduced 1.7%	39,138,499 $2.39 Billion
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $189 Million - $214 Million	-3,359,589 Reduced 7.78%	39,813,485 $2.39 Billion
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $322 Million - $345 Million	-5,999,218 Reduced 12.2%	43,173,074 $2.46 Billion
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $241 Million - $269 Million	-5,021,130 Reduced 9.27%	49,172,292 $2.62 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	54,193,422	54,193,422 $2.63 Billion

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $237B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Abbott Laboratories Transaction History